- Source: Fludiazepam
Fludiazepam, marketed under the brand name Erispan (エリスパン) is a potent benzodiazepine and 2ʹ-fluoro derivative of diazepam, originally developed by Hoffmann-La Roche in the 1960s. It is marketed in Japan and Taiwan. It exerts its pharmacological properties via enhancement of GABAergic inhibition. Fludiazepam has 4 times more binding affinity for benzodiazepine receptors than diazepam. It possesses anxiolytic, anticonvulsant, sedative, hypnotic and skeletal muscle relaxant properties. Fludiazepam has been used recreationally.
See also
Diazepam
Diclazepam (the 2ʹ-chloro analog)
Difludiazepam (the 2',6'-difluoro derivative)
Flunitrazepam (the 7-nitro analog)
Flualprazolam (the triazolo derivative)
Ro20-8552
References
External links
"エリスパンフルジアゼパム錠0.25mg，細粒0.1% Erispan (fludiazepam tablets 0.25 mg, fine granules 0.1%) Prescribing Information" (in Japanese). Sumitomo Dainippon Pharma.
(in Japanese) Official Dainippon Sumitomo Pharma Website Archived 2020-07-01 at the Wayback Machine